Authors: Jarvis, TC Bouhana, KS Lesch, ME Brown, SA Parry, TJ Schrier, DJ Hunt, SW Pavco, PA Flory, CM

Citation: Tc. Jarvis et al., Ribozymes as tools for therapeutic target validation in arthritis, J IMMUNOL, 165(1), 2000, pp. 493-498

Authors: Laemont, KD Schaefer, CJ Juneau, PL Schrier, DJ

Citation: Kd. Laemont et al., Effects of the phosphodiesterase inhibitor rolipram on streptococcal cell wall-induced arthritis in rats, INT J IMMUN, 21(11), 1999, pp. 711-725

Authors: Song, YT Connor, DT Doubleday, R Sorenson, RJ Sercel, AD Unangst, PC Roth, BD Gilbertsen, RB Chan, K Schrier, DJ Guglietta, A Bornemeier, DA Dyer, RD

Citation: Yt. Song et al., Synthesis, structure - Activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, andorally active cyclooxygenase-2 inhibitors. 1. Thiazolone and oxazolone series, J MED CHEM, 42(7), 1999, pp. 1151-1160

Authors: Song, YT Connor, DT Sercel, AD Sorenson, RJ Doubleday, R Unangst, PC Roth, BD Beylin, VG Gilbertsen, RB Chan, K Schrier, DJ Guglietta, A Bornemeier, DA Dyer, RD

Citation: Yt. Song et al., Synthesis, structure - Activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, andorally active cyclooxygenase-2 inhibitors. 2. 1,3,4- and 1,2,4-thiadiazoleseries, J MED CHEM, 42(7), 1999, pp. 1161-1169